Portal de Periódicos da CAPES

The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's hospital studies

1988; Wiley; Volume: 6; Issue: 2 Linguagem: Inglês

10.1002/hon.2900060218

1099-1069

Peter J. Selby, G. Zulian, Garry Forgeson, Anne Nandi, Sarah Milan, M Meldrum, C. Viner, Richard H. Osborne, J. S. Malpas, T J McElwain,

Cancer therapeutics and mechanisms

Hematological OncologyVolume 6, Issue 2 p. 173-179 Article The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's hospital studies Dr. P. Selby, Corresponding Author Dr. P. Selby Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorG. Zulian, G. Zulian Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorG. Forgeson, G. Forgeson Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorAnne Nandi, Anne Nandi Department of Haematology and Computing, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorSarah Milan, Sarah Milan Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorMary Meldrum, Mary Meldrum Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorChristine Viner, Christine Viner Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorR. Osborne, R. Osborne Imperial Cancer Research Fund, Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, U.K.Search for more papers by this authorJ. S. Malpas, J. S. Malpas Imperial Cancer Research Fund, Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, U.K.Search for more papers by this authorT. J. McElwain, T. J. McElwain Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this author Dr. P. Selby, Corresponding Author Dr. P. Selby Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorG. Zulian, G. Zulian Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorG. Forgeson, G. Forgeson Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorAnne Nandi, Anne Nandi Department of Haematology and Computing, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorSarah Milan, Sarah Milan Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorMary Meldrum, Mary Meldrum Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorChristine Viner, Christine Viner Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this authorR. Osborne, R. Osborne Imperial Cancer Research Fund, Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, U.K.Search for more papers by this authorJ. S. Malpas, J. S. Malpas Imperial Cancer Research Fund, Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, U.K.Search for more papers by this authorT. J. McElwain, T. J. McElwain Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Downs Road, Sutton, Surrey SM2 5PT, U.K.Search for more papers by this author First published: April/June 1988 https://doi.org/10.1002/hon.2900060218Citations: 27AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Barlogie, B., Smith, L., Alexanian, R. (1984). Effective treatment of advanced multiple myeloma refractory to alkylating agents. New Engl. J. Med., 310, 1353. Forgeson, G., Selby, P., Lakhani, S., Zulian, G., Viner, C., Maitland, J., McElwain, T. J. (1988). Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients. Submitted for publication. Maclennan, I. (1988). The MRC Myeloma Studies, Blenheim Palace Myeloma Workshop 1987. Hematol. Oncol. McElwain, T. J., Powles, R. L. (1983). High dose intravenous melphalan for plasma cell leukaemia and myeloma. Lancet, ii, 822–824. Selby, P., Ayliffe, M., Behrens, J., McElwain, T. J. (1985). High dose treatment with melphalan and methylprednisolone for multiple myeloma. In: J. Radl, W. Hijmans, B. Van Camp, eds. Monoclonal Gammopathies Clinical Significance and Basic Mechanisms. Topics in Ageing Research in Europe, 5. Rekjavik: European Organisation for Research on Ageing 151–155. Selby, P. J., McElwain, T. J., Nandi, A. C., Perren, T. J., Powles, R. L., Tillyer, C. R., Osborne, R. J., Slevin, M. L., Malpas, J. S. (1987). Multiple myeloma treated with high dose intravenous melphalan. Brit. J. Haematol., 66, 55–62. Citing Literature Volume6, Issue2April/June 1988Pages 173-179 ReferencesRelatedInformation